MYOS Signs Distribution Deal, Sees Year One Sales Exceeding $5 Million
May 22, 2012 08:29 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 22, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
Atlas Therapeutics Changes Its Name and Ticker Symbol to MYOS Corporation and "MYOS"; Launches New Corporate Website
May 21, 2012 06:55 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 21, 2012) - Atlas Therapeutics Corporation (OTCBB: ATTH) (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health...
Drug Sponsors' Regulatory Experience Was Mixed During PDUFA IV, According to Tufts Center for the Study of Drug Development
May 09, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - May 9, 2012) - Drug sponsors experienced a mixed regulatory burden under the FDA Amendments Act, which was also the fourth iteration of the Prescription Drug User Fee Act...
Cardiome Receives Notification From NASDAQ
May 04, 2012 18:01 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, May 4, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) ("the Company") today announced that it received written notification from The NASDAQ Stock...
Drug Companies Are Looking to Shorten Time to Early Clinical Development, According to Tufts Center for the Study of Drug Development
April 26, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Apr 26, 2012) - Drug companies looking to increase the efficiency and productivity of their R&D pipelines are turning to a host of techniques and approaches aimed at...
Stellar Biotechnologies Launches KLH Site(TM)
April 25, 2012 10:47 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Apr 25, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) announced today the launch of KLH Site™ at...
Vista Partners Initiates Coverage on Ohr Pharmaceutical, Inc.; Target Price $2.20
April 17, 2012 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Apr 17, 2012) - Vista Partners announced today that it has initiated coverage on Ohr Pharmaceutical, Inc. (OTCBB: OHRP) ("The Company" or "OHR") with a twelve month...
Heumann Environmental Hires The Tennant Company as Manufacturer Rep
April 09, 2012 08:45 ET
|
Heumann Environmental
LOUISVILLE, Ky., April 9, 2012 (GLOBE NEWSWIRE) -- Heumann Environmental Company, which custom designs and manufactures specialized separation equipment for industrial process and air pollution...
Stellar Biotechnologies Launches Stellar KLH(TM) ELISA Test Kits
April 03, 2012 09:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Apr 3, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable manufacture of...
Boston Therapeutics Is Quoted as BTHE on the OTC Bulletin Board
March 22, 2012 07:00 ET
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Mar 22, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that the Company's common stock was quoted on...